XORTX Therapeutics Inc (XRTX)

NASDAQ: XRTX · IEX Real-Time Price · USD
1.32
-0.08 (-5.71%)
At close: May 20, 2022 4:00 PM
1.34
0.02 (1.52%)
After-hours:May 20, 2022 4:00 PM EDT

Income Statement (Quarterly)

Millions USD. Fiscal year is Jan - Dec.
Quarter Ended2022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-30
Selling, General & Admin
0.710.590.250.160.280.210.110.11
Research & Development
2.440.430.380.030.010.140.120.01
Other Operating Expenses
0.490.59-0.230.680.470.10.150.25
Operating Expenses
3.641.610.40.870.770.440.380.37
Operating Income
-3.64-1.61-0.4-0.87-0.77-0.44-0.38-0.37
Interest Expense / Income
-00000000
Other Expense / Income
-0.21-10.77.95-0.651.40.010.04-0
Pretax Income
-3.429.09-8.35-0.22-2.17-0.45-0.42-0.37
Net Income
-3.429.09-8.35-0.22-2.17-0.45-0.42-0.37
Net Income Common
-3.429.09-8.35-0.22-2.17-0.45-0.42-0.37
Shares Outstanding (Basic)
1310998777
Shares Outstanding (Diluted)
1310998777
Shares Change
57.76%42.38%35.96%35.60%----
EPS (Basic)
-0.261.02-0.89-0.02-0.26-0.06-0.06-0.05
EPS (Diluted)
-0.261.02-0.89-0.02-0.26-0.06-0.06-0.05
Free Cash Flow Per Share
-0.24-0.40-0.01--0.140.23-0.02-
EBITDA
-3.429.1-8.35--2.17-0.45-0.42-
EBIT
-3.439.1-8.35-0.22-2.17-0.45-0.42-0.37
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).